| Year |
Title |
Altmetric |
| 2023
|
Outcome prediction by the 2022 European LeukemiaNet genetic-risk classification for adults with acute myeloid leukemia: an Alliance study.
Leukemia.
2023
|
|
| 2022
|
High early death rates, treatment resistance, and short survival of Black adolescents and young adults with AML.
Blood Advances.
6:5570-5581.
2022
|
|
| 2022
|
The genomic landscape of pediatric acute lymphoblastic leukemia.
Nature Genetics.
54:1376-1389.
2022
|
|
| 2022
|
Clinical and molecular relevance of genetic variants in the non-coding transcriptome of patients with cytogenetically normal acute myeloid leukemia.
The hematology journal : the official journal of the European Haematology Association / EHA.
107:1034-1044.
2022
|
|
| 2022
|
Outstanding outcomes in infants with KMT2Agermline acute lymphoblastic leukemia treated with chemotherapy alone: results of the Children’s Oncology Group AALL0631 trial.
The hematology journal : the official journal of the European Haematology Association / EHA.
107:1205-1208.
2022
|
|
| 2022
|
Sex-based disparities in outcome in pediatric acute lymphoblastic leukemia: a Children’s Oncology Group report.
Cancer.
128:1863-1870.
2022
|
|
| 2022
|
Molecular, clinical, and prognostic implications of PTPN11 mutations in acute myeloid leukemia.
Blood Advances.
6:1371-1380.
2022
|
|
| 2022
|
Outcomes in adolescent and young adult patients (16 to 30 years) compared to younger patients treated for high-risk B-lymphoblastic leukemia: report from Children’s Oncology Group Study AALL0232.
Leukemia.
36:648-655.
2022
|
|
| 2022
|
VpreB surrogate light chain expression in B-lineage ALL: A report from the Children's Oncology Group.
Blood Advances.
6:585-589.
2022
|
|
| 2022
|
Therapy-related Myeloid Neoplasms in Children: A Single-institute Study.
Journal of Pediatric Hematology/Oncology.
44:E109-E113.
2022
|
|
| 2021
|
Establishment and genomic characterization of a sporadic malignant peripheral nerve sheath tumor cell line.
Scientific Reports.
11.
2021
|
|
| 2021
|
Precision oncology in AML: validation of the prognostic value of the knowledge bank approach and suggestions for improvement.
Journal of Hematology and Oncology.
14.
2021
|
|
| 2021
|
HUGO Gene Nomenclature Committee (HGNC) recommendations for the designation of gene fusions.
Leukemia.
35:3040-3043.
2021
|
|
| 2021
|
Phase 3 randomized trial of chemotherapy with or without oblimersen in older AML patients: CALGB 10201 (Alliance).
Blood Advances.
5:2775-2787.
2021
|
|
| 2021
|
Favorable Trisomies and ETV6-RUNX1 Predict Cure in Low-Risk B-Cell Acute Lymphoblastic Leukemia: Results From Children’s Oncology Group Trial AALL0331.
Journal of Clinical Oncology.
39:1540-1553.
2021
|
|
| 2021
|
Correction to: FLT3 inhibitor lestaurtinib plus chemotherapy for newly diagnosed KMT2A-rearranged infant acute lymphoblastic leukemia: Children’s Oncology Group trial AALL0631 (Leukemia, (2021), 35, 5, (1279-1290), 10.1038/s41375-021-01177-6).
Leukemia.
35:1527.
2021
|
|
| 2021
|
Excellent Outcomes With Reduced Frequency of Vincristine and Dexamethasone Pulses in Standard-Risk B-Lymphoblastic Leukemia: Results From Children's Oncology Group AALL0932.
Journal of Clinical Oncology.
39:1437-1447.
2021
|
|
| 2021
|
FLT3 inhibitor lestaurtinib plus chemotherapy for newly diagnosed KMT2A-rearranged infant acute lymphoblastic leukemia: Children’s Oncology Group trial AALL0631.
Leukemia.
35:1279-1290.
2021
|
|
| 2021
|
Prognostic impact of minimal residual disease at the end of consolidation in NCI standard-risk B-lymphoblastic leukemia: A report from the Children's Oncology Group.
Pediatric Blood and Cancer.
68.
2021
|
|
| 2021
|
Gene expression signature predicts relapse in adult patients with cytogenetically normal acute myeloid leukemia.
Blood Advances.
5:1474-1482.
2021
|
|
| 2021
|
Poor survival and differential impact of genetic features of black patients with acute myeloid leukemia.
Cancer Discovery.
11:626-637.
2021
|
|
| 2020
|
Additional gene mutations may refine the 2017 European LeukemiaNet classification in adult patients with de novo acute myeloid leukemia aged <60 years.
Leukemia.
34:3215-3227.
2020
|
|
| 2020
|
Mutational landscape and clinical outcome of patients with de novo acute myeloid leukemia and rearrangements involving 11q23/KMT2A
2020
|
|
| 2020
|
Children's oncology group AALL0434: A phase III randomized clinical trial testing nelarabine in newly diagnosed t-cell acute lymphoblastic leukemia.
Journal of Clinical Oncology.
38:3282-3293.
2020
|
|
| 2020
|
Impact of intrathecal triple therapy versus intrathecal methotrexate on disease-free survival for high-risk B-lymphoblastic leukemia: Children⇔s Oncology Group Study AALL1131.
Journal of Clinical Oncology.
38:2628-2638.
2020
|
|
| 2020
|
Randomized assessment of delayed intensification and two methods for parenteral methotrexate delivery in childhood B-ALL: Children’s Oncology Group Studies P9904 and P9905.
Leukemia.
34:1006-1016.
2020
|
|
| 2020
|
Mutations associated with a 17-gene leukemia stem cell score and the score’s prognostic relevance in the context of the European LeukemiaNet classification of acute myeloid leukemia.
The hematology journal : the official journal of the European Haematology Association / EHA.
105:721-729.
2020
|
|
| 2020
|
Outcome in children with standard-risk b-cell acute lymphoblastic leukemia: Results of children's oncology group trial aall0331.
Journal of Clinical Oncology.
38:602-612.
2020
|
|
| 2020
|
Clinical and molecular characterization of patients with acute myeloid leukemia and sole trisomies of chromosomes 4, 8, 11, 13 or 21.
Leukemia.
34:358-368.
2020
|
|
| 2020
|
Mixed-phenotype acute leukemia: A cohort and consensus research strategy from the Children’s Oncology Group Acute Leukemia of Ambiguous Lineage Task Force.
Cancer.
126:593-601.
2020
|
|
| 2020
|
Clinical and functional significance of circular RNAs in cytogenetically normal AML.
Blood Advances.
4:239-251.
2020
|
|
| 2019
|
Response to interferon treatment in essential thrombocythemia with inv(3)(q21q26).
Annals of Hematology.
98:2845-2846.
2019
|
|
| 2019
|
Genetic characterization and prognostic relevance of acquired uniparental disomies in cytogenetically normal acute myeloid leukemia.
Clinical Cancer Research.
25:6524-6531.
2019
|
|
| 2019
|
Inherited genetic susceptibility to acute lymphoblastic leukemia in down syndrome.
Blood.
134:1227-1237.
2019
|
|
| 2019
|
Masked hypodiploidy: Hypodiploid acute lymphoblastic leukemia (ALL) mimicking hyperdiploid ALL in children: A report from the Children's Oncology Group.
Cancer Genetics.
238:62-68.
2019
|
|
| 2019
|
Complex karyotype in de novo acute myeloid leukemia: typical and atypical subtypes differ molecularly and clinically.
Leukemia.
33:1620-1634.
2019
|
|
| 2019
|
Replacing cyclophosphamide/cytarabine/ mercaptopurine with cyclophosphamide/ etoposide during consolidation/delayed intensification does not improve outcome for pediatric B-cell acute lymphoblastic leukemia: A report from the COG.
The hematology journal : the official journal of the European Haematology Association / EHA.
104:986-992.
2019
|
|
| 2019
|
Genetic characterization and therapeutic targeting of MYC-rearranged T cell acute lymphoblastic leukaemia.
British Journal of Haematology.
185:169-174.
2019
|
|
| 2019
|
Targeting EIF4E signaling with ribavirin in infant acute lymphoblastic leukemia.
Oncogene.
38:2241-2262.
2019
|
|
| 2019
|
Genome-wide association study identifies an acute myeloid leukemia susceptibility locus near BICRA.
Leukemia.
33:771-775.
2019
|
|
| 2019
|
Hematopoietic stem-cell transplantation does not improve the poor outcome of children with hypodiploid acute lymphoblastic leukemia: A report from children's oncology group.
Journal of Clinical Oncology.
37:780-789.
2019
|
|
| 2019
|
Impact of corticosteroid pretreatment in pediatric patients with newly diagnosed B-lymphoblastic leukemia: A report from the Children's Oncology Group.
The hematology journal : the official journal of the European Haematology Association / EHA.
104:E517-E520.
2019
|
|
| 2019
|
Prognostic and biologic relevance of clinically applicable long noncoding RNA profiling in older patients with cytogenetically normal acute myeloid leukemia.
Molecular Cancer Therapeutics.
18:1451-1459.
2019
|
|
| 2018
|
NF1 mutations are recurrent in adult acute myeloid leukemia and confer poor outcome.
Leukemia.
32:2536-2545.
2018
|
|
| 2018
|
Improved survival for children and young adults with t-lineage acute lymphoblastic leukemia: Results from the children's oncology Group AALL0434 methotrexate randomization.
Journal of Clinical Oncology.
36:2926-2934.
2018
|
|
| 2018
|
Genomic and outcome analyses of Ph-like ALL in NCI standard-risk patients: a report from the children’s oncology group.
Blood.
132:815-824.
2018
|
|
| 2018
|
Dasatinib plus intensive chemotherapy in children, adolescents, and young adults with philadelphia chromosome–positive acute lymphoblastic leukemia: Results of children’s oncology group trial AALL0622.
Journal of Clinical Oncology.
36:2306-2313.
2018
|
|
| 2018
|
Ten-year outcome of patients with acute myeloid leukemia not treated with allogeneic transplantation in first complete remission.
Blood Advances.
2:1645-1650.
2018
|
|
| 2018
|
Flow-cytometric vs. -morphologic assessment of remission in childhood acute lymphoblastic leukemia: A report from the Children's Oncology Group (COG).
Leukemia.
32:1370-1379.
2018
|
|
| 2018
|
Mutation patterns identify adult patients with de novo acute myeloid leukemia aged 60 years or older who respond favorably to standard chemotherapy: An analysis of Alliance studies.
Leukemia.
32:1338-1348.
2018
|
|
| 2018
|
Toxicity associated with intensive postinduction therapy incorporating clofarabine in the very high-risk stratum of patients with newly diagnosed high-risk B-lymphoblastic leukemia: A report from the Children's Oncology Group study AALL1131.
Cancer.
124:1150-1159.
2018
|
|
| 2018
|
TP53 germline variations influence the predisposition and prognosis of b-cell acute lymphoblastic leukemia in children.
Journal of Clinical Oncology.
36:591-599.
2018
|
|
| 2017
|
Flow cytometric vs morphologic assessment of remission in childhood acute lymphoblastic leukemia: A report from the Children's Oncology Group (COG)..
Leukemia.
2017
|
|
| 2017
|
Klinefelter syndrome and 47,XYY syndrome in children with B cell acute lymphoblastic leukaemia.
British Journal of Haematology.
179:843-846.
2017
|
|
| 2017
|
The mutational oncoprint of recurrent cytogenetic abnormalities in adult patients with de novo acute myeloid leukemia.
Leukemia.
31:2211-2218.
2017
|
|
| 2017
|
Impact of initial CSF findings on outcome among patients with National Cancer Institute standard- and high-risk B-cell acute lymphoblastic leukemia: A report from the Children’s Oncology Group.
Journal of Clinical Oncology.
35:2527-2534.
2017
|
|
| 2017
|
The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia.
Nature Genetics.
49:1211-1218.
2017
|
|
| 2017
|
Prognostic and biologic significance of long non-coding RNA profiling in younger adults with cytogenetically normal acute myeloid leukemia.
The hematology journal : the official journal of the European Haematology Association / EHA.
102:1391-1400.
2017
|
|
| 2017
|
Targetable kinase gene fusions in high-risk B-ALL: A study from the Children's Oncology Group.
Blood.
129:3352-3361.
2017
|
|
| 2017
|
Mutations in the CCND1 and CCND2 genes are frequent events in adult patients with t(8;21)(q22;q22) acute myeloid leukemia.
Leukemia.
31:1278-1285.
2017
|
|
| 2017
|
No evidence for microsatellite instability in acute myeloid leukemia.
Leukemia.
31:1474-1476.
2017
|
|
| 2017
|
Clinical relevance of small copy-number variants in chromosomal microarray clinical testing.
Genetics in Medicine.
19:377-385.
2017
|
|
| 2017
|
Mutational landscape and gene expression patterns in adult acute myeloid Leukemias with Monosomy 7 as a sole abnormality.
Cancer Research.
77:207-218.
2017
|
|
| 2016
|
Adult acute myeloid leukemia with trisomy 11 as the sole abnormality is characterized by the presence of five distinct gene mutations: MLL-PTD, DNMT3A, U2AF1, FLT3-ITD and IDH2.
Leukemia.
30:2254-2258.
2016
|
|
| 2016
|
MLL rearrangements impact outcome in HOXA-deregulated T-lineage acute lymphoblastic leukemia: A Children's Oncology Group Study.
Leukemia.
30:1909-1912.
2016
|
|
| 2016
|
A pilot study of intensified PEG-asparaginase in high-risk acute lymphoblastic leukemia: Children's oncology group study AALL08P1.
Journal of Pediatric Hematology/Oncology.
38:409-412.
2016
|
|
| 2016
|
Dexamethasone and high-dose methotrexate improve outcome for children and young adults with high-risk B-acute lymphoblastic leukemia: A report from children's oncology group study AALL0232.
Journal of Clinical Oncology.
34:2380-2388.
2016
|
|
| 2016
|
Clinical features and gene-and microRNA-expression patterns in adult acute leukemia patients with t(11;19)(q23;p13.1) and t(11;19)(q23;p13.3).
Leukemia.
30:1586-1589.
2016
|
|
| 2016
|
Outcome of Children with Standard-Risk T-Lineage Acute Lymphoblastic Leukemia—Comparison among Different Treatment Strategies.
Pediatric Blood and Cancer.
63:255-261.
2016
|
|
| 2016
|
Chromosome abnormalities at onset of complete remission are associated with worse outcome in patients with acute myeloid leukemia and an abnor mal kar yotype at diagnosis: CALGB 8461 (alliance).
The hematology journal : the official journal of the European Haematology Association / EHA.
101:1516-1523.
2016
|
|
| 2016
|
Family history of hematologic malignancies and risk of multiple myeloma: differences by race and clinical features.
Cancer Causes and Control.
27:81-91.
2016
|
|
| 2016
|
Overview of clinical cytogenetics.
Current protocols in human genetics / editorial board, Jonathan L. Haines ... [et al.].
2016:8.1.1-8.1.13.
2016
|
|
| 2015
|
Prognostic significance of minimal residual disease in high risk B-ALL: A report from Children's Oncology Group study AALL0232.
Blood.
126:964-971.
2015
|
|
| 2015
|
Variations in dysfunction of sister chromatid cohesion in esco2 mutant zebrafish reflect the phenotypic diversity of Roberts syndrome.
Disease Models and Mechanisms.
8:941-955.
2015
|
|
| 2015
|
Partial trisomy 21: A fifty-year follow-up visit.
American Journal of Medical Genetics Part A.
167:1610-1613.
2015
|
|
| 2015
|
Safe integration of nelarabine into intensive chemotherapy in newly diagnosed T-cell acute lymphoblastic leukemia: Children's Oncology group Study AALL0434.
Pediatric Blood and Cancer.
62:1176-1183.
2015
|
|
| 2015
|
Prognostic and biologic significance of DNMT3B expression in older patients with cytogenetically normal primary acute myeloid leukemia.
Leukemia.
29:567-575.
2015
|
|
| 2015
|
Intensified chemotherapy without SCT in infant ALL: Results from COG P9407 (Cohort 3).
Pediatric Blood and Cancer.
62:419-426.
2015
|
|
| 2015
|
Lymphoid neoplasia: A genome-wide association study of susceptibility to acute lymphoblastic leukemia in adolescents and young adults.
Blood.
125:680-686.
2015
|
|
| 2015
|
Integration of cytogenomic data for furthering the characterization of pediatric B-cell acute lymphoblastic leukemia: A multi-institution, multi-platform microarray study.
Cancer Genetics.
208:1-18.
2015
|
|
| 2014
|
Expression and prognostic impact of lncRNAs in acute myeloid leukemia
2014
|
|
| 2014
|
Pharmacokinetic and pharmacodynamic properties of calaspargase pegol Escherichia coli L-asparaginase in the treatment of patients with acute lymphoblastic leukemia: Results from children's oncology group study AALL07P4.
Journal of Clinical Oncology.
32:3874-3882.
2014
|
|
| 2014
|
T-DNA-induced chromosomal translocations in feronia and anxur2 mutants reveal implications for the mechanism of collapsed pollen due to chromosomal rearrangements.
Molecular Plant.
7:1591-1594.
2014
|
|
| 2014
|
Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia.
New England Journal of Medicine.
371:1005-1015.
2014
|
|
| 2014
|
SPARC promotes leukemic cell growth and predicts acute myeloid leukemia outcome.
Journal of Clinical Investigation.
124:1512-1524.
2014
|
|
| 2014
|
Epigenetics meets genetics in acute myeloid leukemia: Clinical impact of a novel seven-gene score.
Journal of Clinical Oncology.
32:548-556.
2014
|
|
| 2014
|
Cytogenetics and outcome of infants with acute lymphoblastic leukemia and absence of MLL rearrangements.
Leukemia.
28:428-430.
2014
|
|
| 2014
|
Intensive induction is effective in selected octogenarian acute myeloid leukemia patients: Prognostic significance of karyotype and selected molecular markers used in the European LeukemiaNet classification.
The hematology journal : the official journal of the European Haematology Association / EHA.
99:308-313.
2014
|
|
| 2014
|
An international study of intrachromosomal amplification of chromosome 21 (iAMP21): Cytogenetic characterization and outcome.
Leukemia.
28:1015-1021.
2014
|
|
| 2014
|
Constitutional and somatic rearrangement of chromosome 21 in acute lymphoblastic leukaemia.
Nature.
508:98-102.
2014
|
|
| 2014
|
GAS6 expression identifies high-risk adult AML patients: Potential implications for therapy.
Leukemia.
28:1252-1258.
2014
|
|
| 2014
|
Identification and use of fluorescent dyes for plant cell wall imaging using high-throughput screening.
Methods in Molecular Biology.
1056:103-109.
2014
|
|
| 2014
|
Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: Children's oncology group study AALL0031.
Leukemia.
28:1467-1471.
2014
|
|
| 2014
|
Philadelphia chromosome-negative very high-risk acute lymphoblastic leukemia in children and adolescents: Results from children's oncology group study AALL0031.
Leukemia.
28:964-967.
2014
|
|
| 2014
|
Prognostic gene mutations and distinct gene- and microRNA-expression signatures in acute myeloid leukemia with a sole trisomy 8.
Leukemia.
28:1754-1758.
2014
|
|
| 2014
|
The recurrent distal 22q11.2 microdeletions are often de novo and do not represent a single clinical entity: A proposed categorization system.
Genetics in Medicine.
16:92-100.
2014
|
|
| 2013
|
A stem cell-like gene expression signature associates with inferior outcomes and a distinct microRNA expression profile in adults with primary cytogenetically normal acute myeloid leukemia.
Leukemia.
27:2023-2031.
2013
|
|
| 2013
|
Intrachromosomal amplification of chromosome 21 is associated with inferior outcomes in children with acute lymphoblastic leukemia treated in contemporary standard-risk children's oncology group studies: A report from the children's oncology group.
Journal of Clinical Oncology.
31:3397-3402.
2013
|
|
| 2013
|
Lotus Cell Walls and the Genes Involved in its Synthesis and Modification.
Tropical Plant Biology.
6:152-160.
2013
|
|
| 2013
|
Reply to K. Orendi et al.
Journal of Clinical Oncology.
31:2361-2362.
2013
|
|
| 2013
|
Clinical role of micrornas in cytogenetically normal acute myeloid leukemia: MiR-155 Upregulation independently identifies high-risk patients.
Journal of Clinical Oncology.
31:2086-2093.
2013
|
|
| 2013
|
Genome of the long-living sacred lotus (Nelumbo nucifera Gaertn.).
Genome Biology.
14.
2013
|
|
| 2013
|
New recurrent balanced translocations in acute myeloid leukemia and myelodysplastic syndromes: Cancer and leukemia group B 8461
2013
|
|
| 2013
|
The genomic landscape of hypodiploid acute lymphoblastic leukemia.
Nature Genetics.
45:242-252.
2013
|
|
| 2013
|
Inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations.
Blood.
121:385-391.
2013
|
|
| 2013
|
Potent obatoclax cytotoxicity and activation of triple death mode killing across infant acute lymphoblastic leukemia.
Blood.
121:2689-2703.
2013
|
|
| 2012
|
Prognostic significance of the European LeukemiaNet standardized system for reporting cytogenetic and molecular alterations in adults with acute myeloid leukemia.
Journal of Clinical Oncology.
30:4515-4523.
2012
|
|
| 2012
|
Endoscopic ultrasound and endobronchial ultrasound-guided fine-needle aspiration of deep-seated lymphadenopathy: Analysis of 1338 cases.
CytoJournal.
9.
2012
|
|
| 2012
|
XAX1 from glycosyltransferase family 61 mediates xylosyltransfer to rice xylan
2012
|
|
| 2012
|
Treatment-influenced associations of PML-RARα mutations, FLT3 mutations, and additional chromosome abnormalities in relapsed acute promyelocytic leukemia.
Blood.
120:2098-2108.
2012
|
|
| 2012
|
Pediatric acute lymphoblastic leukemia with a t(8;14)(q11.2;q32): B-cell disease with a high proportion of Down syndrome: A Children's Oncology Group study.
Cancer Genetics.
205:453-458.
2012
|
|
| 2012
|
RUNX1 mutations are associated with poor outcome in younger and older patients with cytogenetically normal acute myeloid leukemia and with distinct gene and microRNA expression signatures.
Journal of Clinical Oncology.
30:3109-3118.
2012
|
|
| 2012
|
The MLL partial tandem duplication in adults aged 60 years and older with de novo cytogenetically normal acute myeloid leukemia.
Leukemia.
26:1713-1717.
2012
|
|
| 2012
|
Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: A Children's Oncology Group Study.
Blood.
119:3512-3522.
2012
|
|
| 2012
|
Age-related prognostic impact of different types of DNMT3A mutations in adults with primary cytogenetically normal acute myeloid leukemia.
Journal of Clinical Oncology.
30:742-750.
2012
|
|
| 2012
|
Gene expression profiles predictive of outcome and age in infant acute lymphoblastic leukemia: A Children's Oncology Group study.
Blood.
119:1872-1881.
2012
|
|
| 2012
|
Complex analysis of a recurrent pleomorphic hyalinizing angiectatic tumor of soft parts.
Human Pathology.
43:121-126.
2012
|
|
| 2012
|
Complexes with mixed primary and secondary cellulose synthases are functional in Arabidopsis plants.
Plant Physiology.
160:726-737.
2012
|
|
| 2012
|
Isolation and proteomic characterization of the arabidopsis golgi defines functional and novel components involved in plant cell wall biosynthesis.
Plant Physiology.
159:12-26.
2012
|
|
| 2011
|
ASXL1 mutations identify a high-risk subgroup of older patients with primary cytogenetically normal AML within the ELN Favorable genetic category.
Blood.
118:6920-6929.
2011
|
|
| 2011
|
Low expression of MN1 associates with better treatment response in older patients with de novo cytogenetically normal acute myeloid leukemia.
Blood.
118:4188-4198.
2011
|
|
| 2011
|
Augmented therapy improves outcome for pediatric high risk acute lymphocytic leukemia: Results of Children's Oncology Group trial P9906.
Pediatric Blood and Cancer.
57:569-577.
2011
|
|
| 2011
|
Clinical outcome and gene- and microRNA-expression profiling according to the wilms tumor 1 (WT1) single nucleotide polymorphism rs16754 in adult de novo cytogenetically normal acute myeloid leukemia: A cancer and leukemia group B study.
The hematology journal : the official journal of the European Haematology Association / EHA.
96:1488-1495.
2011
|
|
| 2011
|
Clinically relevant single gene or intragenic deletions encompassing critical neurodevelopmental genes in patients with developmental delay, mental retardation, and/or autism spectrum disorders.
American Journal of Medical Genetics Part A.
155:2386-2396.
2011
|
|
| 2011
|
Microdeletion/microduplication of proximal 15q11.2 between BP1 and BP2: A susceptibility region for neurological dysfunction including developmental and language delay.
Human Genetics.
130:517-528.
2011
|
|
| 2011
|
Frequency and prognostic implications of JAK 1-3 aberrations in Down syndrome acute lymphoblastic and myeloid leukemia.
Leukemia.
25:1365-1368.
2011
|
|
| 2011
|
Comparison of high-dose methotrexate (HD-MTX) with Capizzi methotrexate plus asparaginase (C-MTX/ASNase) in children and young adults with high-risk acute lymphoblastic leukemia (HR-ALL): A report from the Children's Oncology Group Study AALL0232..
Journal of Clinical Oncology.
29:3.
2011
|
|
| 2011
|
Microarray detection of multiple recurring submicroscopic chromosomal aberrations in pediatric T-cell acute lymphoblastic leukemia.
Leukemia.
25:1042-1046.
2011
|
|
| 2011
|
TET2 mutations improve the new European LeukemiaNet risk classification of acute myeloid leukemia: A cancer and leukemia group B study.
Journal of Clinical Oncology.
29:1373-1381.
2011
|
|
| 2011
|
Understanding plant cellulose synthases through a comprehensive investigation of the cellulose synthase family sequences.
Frontiers in Plant Science.
2.
2011
|
|
| 2011
|
Ancestry and pharmacogenomics of relapse in acute lymphoblastic leukemia.
Nature Genetics.
43:237-241.
2011
|
|
| 2011
|
Analysis of the role of hematopoietic stem-cell transplantation in infants with acute lymphoblastic leukemia in first remission and mll gene rearrangements: A report from the children's oncology group.
Journal of Clinical Oncology.
29:214-222.
2011
|
|
| 2011
|
Genomic profiling in Down syndrome acute lymphoblastic leukemia identifies histone gene deletions associated with altered methylation profiles.
Leukemia.
25:1555-1563.
2011
|
|
| 2011
|
Tamoxifen inhibits malignant peripheral nerve sheath tumor growth in an estrogen receptor-independent manner.
Neuro-Oncology.
13:28-41.
2011
|
|
| 2010
|
Prognostic significance of expression of a single microRNA, miR-181a, in cytogenetically normal acute myeloid leukemia: A cancer and leukemia group B study.
Journal of Clinical Oncology.
28:5257-5264.
2010
|
|
| 2010
|
BAALC and ERG expression levels are associated with outcome and distinct gene and microRNA expression profiles in older patients with de novo cytogenetically normal acute myeloid leukemia: A cancer and leukemia group B study.
Blood.
116:5660-5669.
2010
|
|
| 2010
|
Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: Correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome.
Blood.
116:4874-4884.
2010
|
|
| 2010
|
FLT3 internal tandem duplication associates with adverse outcome and gene- and microRNA-expression signatures in patients 60 years of age or older with primary cytogenetically normal acute myeloid leukemia: A cancer and leukemia group B study.
Blood.
116:3622-3626.
2010
|
|
| 2010
|
Down syndrome childhood acute lymphoblastic leukemia has a unique spectrum of sentinel cytogenetic lesions that influences treatment outcome: A report from the Children's Oncology Group.
Blood.
116:1045-1050.
2010
|
|
| 2010
|
Mutations of the Wilms tumor 1 gene (WT1) in older patients with primary cytogenetically normal acute myeloid leukemia: A Cancer and leukemia group B study.
Blood.
116:788-792.
2010
|
|
| 2010
|
Identification of a cellulose synthase-associated protein required for cellulose biosynthesis
2010
|
|
| 2010
|
Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia.
Blood.
115:5312-5321.
2010
|
|
| 2010
|
Raman imaging of cell wall polymers in Arabidopsis thaliana.
Biochemical and Biophysical Research Communications.
395:521-523.
2010
|
|
| 2010
|
IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: A cancer and leukemia group B study.
Journal of Clinical Oncology.
28:2348-2355.
2010
|
|
| 2010
|
Favorable Prognostic Impact of NPM1 Mutations in Older Patients with Cytogenetically Normal de Novo Acute Myeloid Leukemia and Associated Gene- And MicroRNA-Expression Signatures: A Cancer and Leukemia Group B Study.
Journal of Clinical Oncology.
28:596-604.
2010
|
|
| 2010
|
Real-time imaging of cellulose reorientation during cell wall expansion in Arabidopsis roots.
Plant Physiology.
152:787-796.
2010
|
|
| 2009
|
Improved early event-free survival with imatinib in Philadelphia chromosome - Positive acute lymphoblastic leukemia: A Children's Oncology Group Study.
Journal of Clinical Oncology.
27:5175-5181.
2009
|
|
| 2009
|
Rearrangement of CRLF2 in B-progenitor-and Down syndrome-associated acute lymphoblastic leukemia.
Nature Genetics.
41:1243-1246.
2009
|
|
| 2009
|
Label-free in situ imaging of lignification in the cell wall of low lignin transgenic Populus trichocarpa
2009
|
|
| 2009
|
Molecular cytogenetic characterization of two cases with constitutional distal 11q duplication/triplication.
American Journal of Medical Genetics Part A.
149:1516-1522.
2009
|
|
| 2009
|
Prognostic importance of MN1 transcript levels, and biologic insights from MN1-associated gene and microRNA expression signatures in cytogenetically normal acute myeloid leukemia: A cancer and leukemia group B study.
Journal of Clinical Oncology.
27:3198-3204.
2009
|
|
| 2009
|
Cellulosic biofuels.
Annual Review of Plant Biology.
60:165-182.
2009
|
|
| 2009
|
Prevalence and clinical correlates of JAK2 mutations in Down syndrome acute lymphoblastic leukaemia.
British Journal of Haematology.
144:930-932.
2009
|
|
| 2009
|
Mutations in UDP-glucose:Sterol glucosyltransferase in Arabidopsis cause transparent testa phenotype and suberization defect in seeds.
Plant Physiology.
151:78-87.
2009
|
|
| 2008
|
Distal 22q11.2 microduplication encompassing the BCR gene.
American Journal of Medical Genetics Part A.
146:3075-3081.
2008
|
|
| 2008
|
Prognostic significance of, and gene and MicroRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with high-risk molecular features: A cancer and leukemia group B study.
Journal of Clinical Oncology.
26:5078-5087.
2008
|
|
| 2008
|
Wilms' tumor 1 gene mutations independently predict poor outcome in adults with cytogenetically normal acute myeloid leukemia: A cancer and leukemia group B study.
Journal of Clinical Oncology.
26:4595-4602.
2008
|
|
| 2008
|
Central review of cytogenetics is necessary for cooperative group correlative and clinical studies of adult acute leukemia: The Cancer and Leukemia Group B experience.
International Journal of Oncology.
33:239-244.
2008
|
|
| 2008
|
Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: A Children's Oncology Group study.
Blood.
111:5477-5485.
2008
|
|
| 2008
|
Abundant anti-apoptotic BCL-2 is a molecular target in leukaemias with t(4;11) translocation.
British Journal of Haematology.
141:827-839.
2008
|
|
| 2008
|
MicroRNA expression in cytogenetically normal acute myeloid leukemia.
New England Journal of Medicine.
358:1919-1928.
2008
|
|
| 2007
|
Genetic evidence for three unique components in primary cell-wall cellulose synthase complexes in Arabidopsis
2007
|
|
| 2007
|
A previously unrecognized microdeletion syndrome on chromosome 22 Band q11.2 encompassing the BCR Gene.
American Journal of Medical Genetics Part A.
143:2178-2184.
2007
|
|
| 2007
|
Antimetabolite therapy for lesser-risk B-lineage acute lymphoblastic leukemia of childhood: A report from Children's Oncology Group Study P9201.
Blood.
110:1105-1111.
2007
|
|
| 2007
|
High expression levels of the ETS-related gene, ERG, predict adverse outcome and improve molecular risk-based classification of cytogenetically normal acute myeloid leukemia: A cancer and leukemia group B study.
Journal of Clinical Oncology.
25:3337-3343.
2007
|
|
| 2007
|
Overlapping phenotype of Wolf-Hirschhorn and Beckwith-Wiedemann syndromes in a girl with der(4)t(4;11)(pter;pter).
American Journal of Medical Genetics Part A.
143:1760-1766.
2007
|
|
| 2007
|
Specific extra chromosomes occur in a modal number dependent pattern in pediatric acute lymphoblastic leukemia
2007
|
|
| 2007
|
Long-term disease-free survivors with cytogenetically normal acute myeloid leukemia and MLL partial tandem duplication: A Cancer and Leukemia Group B study.
Blood.
109:5164-5167.
2007
|
|
| 2007
|
Prognostic significance of cytogenetically detected chromosome 21 anomalies in childhood acute lymphoblastic leukemia: a Pediatric Oncology Group study.
Cancer Genetics.
175:117-124.
2007
|
|
| 2007
|
Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: A combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG).
Blood.
109:926-935.
2007
|
|
| 2007
|
Gene expression overlap affects karyotype prediction in pediatric acute lymphoblastic leukemia [17].
Leukemia.
21:1341-1344.
2007
|
|
| 2006
|
Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): A Cancer and Leukemia Group B study.
Journal of Clinical Oncology.
24:3904-3911.
2006
|
|
| 2006
|
Complete trisomy 17p syndrome in a girl with der(14)t(14;17)(p11.2;p11.2).
American Journal of Medical Genetics Part A.
140:1647-1654.
2006
|
|
| 2006
|
Heart disease in pregnancy.
Medicine.
34:307-311.
2006
|
|
| 2006
|
Pretreatment cytogenetics add to other prognostic factors predicting complete remission and long-term outcome in patients 60 years of age or older with acute myeloid leukemia: Results from Cancer and Leukemia Group B 8461.
Blood.
108:63-73.
2006
|
|
| 2006
|
A retrospective study of 69 patients with t(6;9)(p23;q34) AML emphasizes the need for a prospective, multicenter initiative for rare 'poor prognosis' myeloid malignancies [4].
Leukemia.
20:1295-1297.
2006
|
|
| 2006
|
Studies of a novel sensor for assessing the spatial distribution of cavitation activity within ultrasonic cleaning vessels.
Ultrasonics.
44:73-82.
2006
|
|
| 2005
|
Outcome of induction and postremission therapy in younger adults with acute myeloid leukemia with normal karyotype: A cancer and leukemia group B study.
Journal of Clinical Oncology.
23:482-493.
2005
|
|
| 2005
|
Overexpression of the ETS-related gene, ERG, predicts a worse outcome in acute myeloid leukemia with normal karyotype: A Cancer and Leukemia Group B study.
Journal of Clinical Oncology.
23:9234-9242.
2005
|
|
| 2005
|
Prognostic factors and outcome of core binding factor acute myeloid leukemia patients with t(8;21) differ from those of patients with inv(16): A Cancer and Leukemia Group B study.
Journal of Clinical Oncology.
23:5705-5717.
2005
|
|
| 2005
|
High concordance from independent studies by the Children's Cancer Group (CCG) and Pediatric Oncology Group (POG) associating favorable prognosis with combined trisomies 4, 10, and 17 in children with NCI Standard-Risk B-precursor Acute Lymphoblastic Leukemia: A Children's Oncology Group (COG) initiative.
Leukemia.
19:734-740.
2005
|
|
| 2005
|
No prognostic effect of additional chromosomal abnormalities in children with acute lymphoblastic leukemia and 11q23 abnormalities.
Leukemia.
19:557-563.
2005
|
|
| 2005
|
Pediatric Oncology Group (POG) studies of acute myeloid leukemia (AML): A review of four consecutive childhood AML trials conducted between 1981 and 2000.
Leukemia.
19:2101-2116.
2005
|
|
| 2004
|
Abnormal cytogenetics at date of morphologic complete remission predicts short overall and disease-free survival, and higher relapse rate in adult acute myeloid leukemia: Results from Cancer and Leukemia Group B study 8461.
Journal of Clinical Oncology.
22:2410-2418.
2004
|
|
| 2004
|
Repetitive cycles of high-dose cytarabine benefit patients with acute myeloid leukemia and inv(16)(p13q22) or t(16;16)(p13;q22): Results from CALGB 8461.
Journal of Clinical Oncology.
22:1087-1094.
2004
|
|
| 2004
|
Adult de novo acute myeloid leukemia with t(6;11)(q27;q23): Results from cancer and leukemia group B study 8461 and review of the literature.
Cancer.
101:1420-1427.
2004
|
|
| 2004
|
Differences in prognostic factors and outcomes in African Americans and whites with acute myeloid leukemia.
Blood.
103:4036-4042.
2004
|
|
| 2004
|
Congenital Diaphragmatic Hernia: Is 15q26.1-26.2 a Candidate Locus?.
American Journal of Medical Genetics Part A.
126 A:183-185.
2004
|
|
| 2004
|
Congenital diaphragmatic hernia: is 15q26.1-26.2 a candidate locus?.
American Journal of Medical Genetics Part A.
126A:183-185.
2004
|
|
| 2004
|
Additional cytogenetic abnormalities in adults with Philadelphia chromosome-positive acute lymphoblastic leukaemia: A study of the Cancer and Leukaemia Group B.
British Journal of Haematology.
124:275-288.
2004
|
|
| 2004
|
Core binding factor acute myeloid leukemia. Cancer and Leukemia Group B (CALGB) Study 8461..
Annals of Hematology.
83 Suppl 1.
2004
|
|
| 2004
|
Prognostic significance of additional cytogenetic abnormalities in newly diagnosed patients with Philadelphia chromosome-positive chronic myelogenous leukemia treated with interferon-alpha: a Cancer and Leukemia Group B study..
International Journal of Oncology.
25:143-151.
2004
|
|
| 2004
|
Secondary cytogenetic aberrations in childhood Philadelphia chromosome positive acute lymphoblastic leukemia are nonrandom and may be associated with outcome.
Leukemia.
18:693-702.
2004
|
|
| 2003
|
BAALC expression predicts clinical outcome of de novo acute myeloid leukemia patients with normal cytogenetics: A Cancer and Leukemia Group B study.
Blood.
102:1613-1618.
2003
|
|
| 2003
|
Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements.
Leukemia.
17:700-706.
2003
|
|
| 2003
|
Osteosarcoma in a patient with McCune-Albright syndrome and Mazabraud's syndrome: A case report emphasizing the cytological and cytogenetic findings.
Human Pathology.
34:1354-1357.
2003
|
|
| 2003
|
Treatment of the chronic phase of chronic myeloid leukemia with an intermittent schedule of recombinant interferon alfa-2b and cytarabine: Results from CALGB study 9013
2003
|
|
| 2002
|
Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: Results from Cancer and Leukemia Group B (CALGB 8461).
Blood.
100:4325-4336.
2002
|
|
| 2002
|
Isolated trisomy of chromosomes 8, 11, 13 and 21 is an adverse prognostic factor in adults with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B 8461..
International Journal of Oncology.
21:1041-1051.
2002
|
|
| 2002
|
Rare recurring balanced chromosome abnormalities in therapy-related myelodysplastic syndromes and acute leukemia: Report from an international workshop
2002
|
|
| 2001
|
Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: A cancer and leukemia group B study.
Cancer Research.
61:7233-7239.
2001
|
|
| 2001
|
Transient hyperphosphatasaemia: An important condition to recognize.
Journal of Paediatrics and Child Health.
37:359-362.
2001
|
|
| 2001
|
High frequency of immunophenotype changes in acute myeloid leukemia at relapse: Implications for residual disease detection (Cancer and Leukemia Group B Study 8361).
Blood.
97:3574-3580.
2001
|
|
| 2001
|
Comparison of cytogenetic and molecular genetic detection of t(8;21) and inv(16) in a prospective series of adults with de novo acute myeloid leukemia: A cancer and leukemia group B study.
Journal of Clinical Oncology.
19:2482-2492.
2001
|
|
| 2001
|
Prader-Willi syndrome due to maternal uniparental disomy of chromosome 15 in a boy with a balanced 3;21 translocation.
American Journal of Medical Genetics Part A.
100:85-86.
2001
|
|
| 2001
|
T(7;12)(q36;p13) and t(7;12)(q32;p13) - Translocations involving ETV6 in children 18 months of age or younger with myeloid disorders.
Leukemia.
15:915-920.
2001
|
|
| 2000
|
New recurring cytogenetic abnormalities and association of blast cell karyotypes with prognosis in childhood T-cell acute lymphoblastic leukemia: A Pediatric Oncology Group report of 343 cases.
Blood.
96:2543-2549.
2000
|
|
| 2000
|
Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia.
New England Journal of Medicine.
342:998-1006.
2000
|
|
| 2000
|
The t(14;21)(q11.2;q22) chromosomal translocation associated with T-cell acute lymphoblastic leukemia activates the BHLHB1 gene
2000
|
|
| 2000
|
Acute lymphoblastic leukemia with an unusual t(8;14)(q11.2;q32): A Pediatric Oncology Group study.
Leukemia.
14:238-240.
2000
|
|
| 2000
|
Prognostic factors in children and adolescents with acute myeloid leukemia (exluding children with Down syndrome and acute promyelocytic leukemia): Univariate and recursive partitioning analysis of patients treated on Pediatric Oncology Group (POG) Study 8821.
Leukemia.
14:1201-1207.
2000
|
|
| 2000
|
Treatment of children with early pre-B and pre-B acute lymphocytic leukemia with antimetabolite-based intensification regimens: A pediatric oncology group study.
Leukemia.
14:1570-1576.
2000
|
|
| 1999
|
Chromosomal abnormalities in 478 children with acute myeloid leukemia: clinical characteristics and treatment outcome in a cooperative pediatric oncology group study-POG 8821..
Blood.
94:3707-3716.
1999
|
|
| 1999
|
Prospective karyotype analysis in adult acute lymphoblastic leukemia: The cancer and leukemia group B experience.
Blood.
93:3983-3993.
1999
|
|
| 1999
|
Acute lymphoblastic leukemia with the (8;14)(q24;q32) translocation and FAB L3 morphology associated with a B-precursor immunophenotype: The Pediatric Oncology Group experience.
Leukemia.
13:135-141.
1999
|
|
| 1999
|
Childhood acute lymphoblastic leukemia with the MLL-ENL fusion and t(11;19)(q23;p13.3) Translocation.
Journal of Clinical Oncology.
17:191-196.
1999
|
|
| 1999
|
Detection of mosaicism in amniotic fluid cultures: a CYTO2000 collaborative study..
Genetics in Medicine.
1:94-97.
1999
|
|
| 1999
|
Patients with t(8;21)(q22;q22) and acute myeloid leukemia have superior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administered.
Journal of Clinical Oncology.
17:3767-3775.
1999
|
|
| 1999
|
Significance of commonly used prognostic factors differs for children with T cell acute lymphocytic leukemia (ALL), as compared to those with B-precursor ALL, a Pediatric Oncology Group (POG) study.
Leukemia.
13:1696-1707.
1999
|
|
| 1999
|
p27KIP1 Deletions in Childhood Acute Lymphoblastic Leukemia.
Neoplasia.
1:253-261.
1999
|
|
| 1998
|
Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype.
Cancer Research.
58:4173-4179.
1998
|
|
| 1998
|
Identification of BCR-ABL fusion on chromosome 9 by fluorescence in situ hybridization in two chronic myeloid leukemia cases.
Cancer Genetics.
105:164-167.
1998
|
|
| 1998
|
Intensive alternating drug pairs after remission induction for treatment of infants with acute lymphoblastic leukemia: A pediatric oncology group pilot study.
Journal of Pediatric Hematology/Oncology.
20:229-233.
1998
|
|
| 1998
|
Chromosome 18q paracentric inversion in a family with mental retardation and hearing loss.
American Journal of Medical Genetics Part A.
76:372-378.
1998
|
|
| 1998
|
E2A-PBX1 chimeric transcript status at end of consolidation is not predictive of treatment outcome in childhood acute lymphoblastic leukemias with a t(1;19)(q23;p13): A pediatric oncology group study.
Blood.
91:1021-1028.
1998
|
|
| 1998
|
Consolidation therapy with antimetabolite-based therapy in standard- risk acute lymphocytic leukemia of childhood: A pediatric oncology group study.
Journal of Clinical Oncology.
16:2840-2847.
1998
|
|
| 1998
|
Myeloperoxidase gene expression in infant leukemia: A pediatric oncology group study
1998
|
|
| 1998
|
Prevalence of myeloperoxidase gene expression in infant acute lymphocytic leukemia.
American Journal of Clinical Pathology.
110:575-581.
1998
|
|
| 1998
|
Prognostic significance of sex in childhood B-precursor acute lymphoblastic leukemia: A pediatric oncology group study.
Journal of Clinical Oncology.
16:2854-2863.
1998
|
|
| 1997
|
Adult patients with de novo acute myeloid leukemia and t(9;11)(p22;q23) have a superior outcome to patients with other translocations involving band 11q23: A Cancer and Leukemia Group B Study.
Blood.
90:4532-4538.
1997
|
|
| 1997
|
Hyperdiploidy and E2A-PBX1 fusion in an adult with t(1;19)+ acute lymphoblastic leukemia: Case report and review of the literature
1997
|
|
| 1997
|
Prognostic significance of fluorescence intensity of surface marker expression in childhood B-precursor acute lymphoblastic leukemia. A Pediatric Oncology Group study.
Blood.
89:3960-3966.
1997
|
|
| 1997
|
Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): Results from Cancer and Leukemia Group B 8461.
Journal of Clinical Oncology.
15:466-475.
1997
|
|
| 1997
|
Identification of a recombination event narrowing the Lafora disease gene region.
Journal of Medical Genetics.
34:590-591.
1997
|
|
| 1997
|
Secondary cytogenetic changes in acute promyelocytic leukemia - Prognostic importance in patients treated with chemotherapy alone and association with the intron 3 breakpoint of the PML gene: A Cancer and Leukemia Group B study.
Journal of Clinical Oncology.
15:1786-1795.
1997
|
|
| 1997
|
Therapeutic trial for infant acute lymphoblastic leukemia: The pediatric oncology group experience (POG 8493).
Journal of Pediatric Hematology/Oncology.
19:35-42.
1997
|
|
| 1996
|
Molecular analysis of t(11;19) breakpoints in childhood acute leukemias.
Blood.
87:4804-4808.
1996
|
|
| 1996
|
The t(3;5)(q25.1;q34) of myelodysplastic syndrome and acute myeloid leukemia produces a novel fusion gene, NPM-MLF1.
Oncogene.
12:265-275.
1996
|
|
| 1996
|
Comparison of Fluorescence in Situ Hybridization, Cytogenetic Analysis, and DNA Index Analysis to Detect Chromosomes 4 and 10 Aneuploidy in Pediatric Acute Lymphoblastic Leukemia: A Pediatric Oncology Group Study.
Journal of Pediatric Hematology/Oncology.
18:113-121.
1996
|
|
| 1996
|
Improved survival for children with B-cell acute lymphoblastic leukemia and stage IV small noncleaved-cell lymphoma: A Pediatric Oncology Group study.
Journal of Clinical Oncology.
14:1252-1261.
1996
|
|
| 1996
|
Molecular analysis of the PML/RARα chimeric gene in pediatric acute promyelocytic leukemia.
Leukemia.
10:1296-1302.
1996
|
|
| 1996
|
Terminal deletion of the long arm of chromosome 4 in a mother and two sons
1996
|
|
| 1996
|
Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia.
Journal of Clinical Oncology.
14:18-24.
1996
|
|
| 1995
|
Heterogeneity in CBFβ/MYH11 fusion messages encoded by the inv(16)(p13q22) and the t(16;16)(p13;q22) in acute myelogenous leukemia.
Blood.
85:3695-3703.
1995
|
|
| 1995
|
Paracentric inversions in humans: A review of 446 paracentric inversions with presentation of 120 new cases.
American Journal of Medical Genetics Part A.
55:171-187.
1995
|
|
| 1995
|
Chromosome 1p terminal deletion: Report of new findings and confirmation of two characteristic phenotypes.
Journal of Medical Genetics.
32:619-622.
1995
|
|
| 1994
|
Frequency and prognostic significance of HRX rearrangements in infant acute lymphoblastic leukemia: A Pediatric Oncology Group Study.
Blood.
84:570-573.
1994
|
|
| 1994
|
Variant t(8;21) rearrangements in acute myeloblastic leukemia of childhood.
Cancer Genetics.
75:139-144.
1994
|
|
| 1994
|
Presenting characteristics of trisomy 8 as the primary cytogenetic abnormality associated with childhood acute lymphoblastic leukemia. A pediatric oncology group (POG) study (8600/8493).
Cancer Genetics.
75:6-10.
1994
|
|
| 1994
|
The der(11)-encoded MLL/AF-4 fusion transcript is consistently detected in t(4;11)(q21;q23)-containing acute lymphoblastic leukemia.
Blood.
83:330-335.
1994
|
|
| 1994
|
Childhood acute lymphoblastic leukemia with the t(4;11)(q21;q23): An update [4].
Blood.
83:2384-2385.
1994
|
|
| 1994
|
Further definition of 20q deletion in myeloid leukemia using fluorescence in situ hybridization [1].
Blood.
84:2821-2823.
1994
|
|
| 1994
|
Human t(4;11)(q21;q23) acute lymphoblastic leukemia in mice with severe combined immunodeficiency.
Blood.
84:859-865.
1994
|
|
| 1994
|
Simultaneous expression of RBTN-2 and BCR-ABL oncogenes in a T-ALL with a t(11;14)(p13;q11) and a late-appearing Philadelphia chromosome.
Leukemia.
8:1124-1130.
1994
|
|
| 1993
|
DNA fragments of altered electrophoretic mobility in leukemia samples can arise from double-strand DNA breaks at nuclease hypersensitive sites of active genes.
Cancer Genetics.
68:34-41.
1993
|
|
| 1993
|
Alveolar rhabdomyosarcoma with the t(2;13): Cytogenetic findings and clinicopathologic correlations.
Pediatric Blood and Cancer.
21:83-87.
1993
|
|
| 1993
|
An AML1/ETO fusion transcript is consistently detected by RNA-based polymerase chain reaction in acute myelogenous leukemia containing the (8;21)(q22;q22) translocation.
Blood.
81:2860-2865.
1993
|
|
| 1993
|
Clinical features and outcome of T-cell acute lymphoblastic leukemia in childhood with respect to alterations at the TAL1 locus: A Pediatric Oncology Group study.
Blood.
81:2110-2117.
1993
|
|
| 1993
|
Erratum: Management of cytogenetic data in multi-center leukemia trials (Computer Methods and Programs in Biomedicine (1993) 40 (269-277)).
Computer Methods and Programs in Biomedicine.
41:147.
1993
|
|
| 1993
|
HRX involvement in de novo and secondary leukemias with diverse chromosome 11q23 abnormalities.
Blood.
81:3197-3203.
1993
|
|
| 1993
|
Human t(1;19)(q23;p13) pre-B acute lymphoblastic leukemia in mice with severe combined immunodeficiency.
Blood.
81:3052-3059.
1993
|
|
| 1993
|
Immunophenotypes and karyotypes of leukemic cells in children with down syndrome and acute lymphoblastic leukemia.
Journal of Clinical Oncology.
11:1361-1367.
1993
|
|
| 1993
|
Management of cytogenetic data in multi-center leukemia trials.
Computer Methods and Programs in Biomedicine.
40:269-277.
1993
|
|
| 1993
|
Predictability of the t(1;19)(q23;p13) from surface antigen phenotype: Implications for screening cases of childhood acute lymphoblastic leukemia for molecular analysis: A Pediatric Oncology Group study.
Blood.
82:1086-1091.
1993
|
|
| 1993
|
Transitional pre-B-cell acute lymphoblastic leukemia of childhood is associated with favorable prognostic clinical features and an excellent outcome: A pediatric oncology group study.
Leukemia.
7:2064-2068.
1993
|
|
| 1993
|
Trisomy 21 in childhood acute lymphoblastic leukemia: A Pediatric Oncology Group Study (8602).
Blood.
82:3098-3102.
1993
|
|
| 1993
|
Use of clinical and laboratory features to define prognostic subgroups in B-precursor acute lymphoblastic leukemia: experience of the Pediatric Oncology Group..
Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.
131:257-267.
1993
|
|
| 1992
|
Accumulation of high levels of methotrexate polyglutamates in lymphoblasts from children with hyperdiploid (>50 chromosomes) B-lineage acute lymphoblastic leukemia: A Pediatric Oncology Group study.
Blood.
80:1316-1323.
1992
|
|
| 1992
|
Acute megakaryoblastic leukemia in infants with t(1;22)(p13;q13) abnormality.
American Journal of Clinical Pathology.
98:214-221.
1992
|
|
| 1992
|
An Altered 11-Kilobase Transcript in Leukemic Cell Lines with the t(4;11)(q21;q23) chromosome translocation.
Cancer Research.
52:3811-3813.
1992
|
|
| 1992
|
Childhood acute lymphoblastic leukemia with both t(1;19) and t(9;22).
Leukemia.
6:535-540.
1992
|
|
| 1992
|
Different molecular consequences of the 1;19 chromosomal translocation in childhood B-cell precursor acute lymphoblastic leukemia.
Blood.
79:1781-1788.
1992
|
|
| 1992
|
G19.4(αCD3) x B43(αCD19) monoclonal antibody heteroconjugate triggers CD19 antigen-specific lysis of t(4;11) acute lymphoblastic leukemia cells by activated CD3 antigen-positive cytotoxic T cells.
Blood.
80:2826-2834.
1992
|
|
| 1992
|
Isochromosomes in childhood acute lymphoblastic leukemia: A collaborative study of 83 cases.
Blood.
79:2384-2391.
1992
|
|
| 1992
|
Ploidy of lymphoblasts is the strongest predictor of treatment outcome in b-progenitor cell acute lymphoblastic leukemia of childhood: A pediatric oncology group study.
Journal of Clinical Oncology.
10:606-613.
1992
|
|
| 1992
|
The non-random dic(9;12) translocation in acute lymphoblastic leukemia is associated with B-progenitor phenotype and an excellent prognosis.
Leukemia.
6:703-707.
1992
|
|
| 1992
|
The translocation (1;14)(p34;q11) in human t‐cell leukemia: Chromosome breakage 25 kilobase pairs downstream of the tal1 protooncogene
1992
|
|
| 1992
|
Trisomy of leukemic cell chromosomes 4 and 10 identifies children with B- progenitor cell acute lymphoblastic leukemia with a very low risk of treatment failure: A Pediatric Oncology Group Study.
Blood.
79:3316-3324.
1992
|
|
| 1992
|
t(12;17)(p13;q21) in early pre-B acute lymphoid leukemia.
Leukemia.
6:251-255.
1992
|
|
| 1992
|
t(2;14)(p13;q32): A recurring abnormality in lymphocytic leukemia. A pediatric oncology group study.
Cancer Genetics.
58:121-124.
1992
|
|
| 1991
|
A novel human homeobox gene lies at the chromosome 10 breakpoint in lymphoid neoplasias with chromosomal translocation t(10;14).
Blood.
78:2996-3003.
1991
|
|
| 1991
|
Clinical characteristics and treatment outcome of childhood acute lymphoblastic leukemia with the t(4;11)(q21;q23): A collaborative study of 40 cases.
Blood.
77:440-447.
1991
|
|
| 1991
|
Consistent involvement of the BCR gene by 9;22 breakpoints in pediatric acute leukemias.
Blood.
77:324-330.
1991
|
|
| 1991
|
Cytogenetic features of childhood acute lymphoblastic leukemia. A concordance study and a pediatric oncology group study.
Cancer Genetics.
55:249-256.
1991
|
|
| 1991
|
Heterogeneity of the breakpoint localization in malignant cells with a 9p11 chromosomal abnormality.
Leukemia.
5:468-472.
1991
|
|
| 1991
|
Localization of the expressed human p58 protein kinase chromosomal gene to chromosome 1p36 and a highly related sequence to chromosome 15.
Genomics.
11:621-629.
1991
|
|
| 1991
|
Philadelphia chromosome and monosomy 7 in childhood acute lymphoblastic leukemia: A Pediatric Oncology Group study.
Blood.
77:1050-1056.
1991
|
|
| 1991
|
The t(1;19)(q23;p13) results in consistent fusion of E2A and PBX1 coding sequences in acute lymphoblastic leukemias.
Blood.
77:687-693.
1991
|
|
| 1991
|
The t(1;22) (p13;q13) is nonrandom and restricted to infants with acute megakaryoblastic leukemia: A pediatric oncology group study.
Blood.
78:748-752.
1991
|
|
| 1990
|
Coding sequences of the ral-1 gene are disrupted by chromosome translocation in human T cell leukemia.
Journal of Experimental Medicine.
172:1403-1408.
1990
|
|
| 1990
|
Clinical presentation, karyotypic characterization, and treatment outcome of childhood acute lymphoblastic leukemia with a near-haploid or hypodiploid < 45 line.
Blood.
75:1170-1177.
1990
|
|
| 1990
|
Molecular characterization of the t(10;14) translocation breakpoints in T‐cell acute lymphoblastic leukemia: Further evidence for illegitimate physiological recombination
1990
|
|
| 1990
|
Near-triploid and near-tetraploid acute lymphoblastic leukemia of childhood.
Blood.
76:590-596.
1990
|
|
| 1990
|
Philadelphia chromosome positive childhood acute lymphoblastic leukemia: Clinical and cytogenetic characteristics and treatment outcome. A Pediatric Oncology Group study.
Blood.
76:489-494.
1990
|
|
| 1990
|
Poor prognosis of children with pre-B acute lymphoblastic leukemia is associated with the t(1;19) (q23;p13): A pediatric oncology group study.
Blood.
76:117-122.
1990
|
|
| 1990
|
Pre-b-cell acute lymphoblastic leukemia in childhood
1990
|
|
| 1990
|
Prognostic significance of CD34 expression in childhood B-precursor acute lymphocytic leukemia: A pediatric oncology group study.
Journal of Clinical Oncology.
8:1389-1398.
1990
|
|
| 1990
|
The t(10;14)(q24;q11) of T-cell acute lymphoblastic leukemia juxtaposes the δ T-cell receptor with TCL3, a conserved and activated locus at 10q24
1990
|
|
| 1990
|
The t(1;14)(p34;q11) is nonrandom and restricted to T-cell acute lymphoblastic leukemia: A Pediatric Oncology Group study.
Blood.
76:1220-1224.
1990
|
|
| 1990
|
The tal gene undergoes chromosome translocation in T cell leukemia and potentially encodes a helix - loop - helix protein
1990
|
|
| 1989
|
Light-chain gene expression before heavy-chain gene rearrangement in pre-B cells transformed by Epstein-Barr virus
1989
|
|
| 1989
|
Localization of preferential sites of rearrangement within the BCR gene in Philadelphia chromosome-positive acute lymphoblastic leukemia
1989
|
|
| 1989
|
The gene for enhancer binding proteins E12/E47 lies at the t(1;19) breakpoint in acute leukemias.
Science.
246:379-382.
1989
|
|
| 1988
|
Aneuploidy and the fragile X syndrome.
American Journal of Medical Genetics Part A.
30:115-121.
1988
|
|
| 1988
|
Bone marrow origin of a B-cell lymphoma.
Blood.
72:94-101.
1988
|
|
| 1988
|
Interstitial deletion of chromosome 1 [del(1)(q25q32)] in an infant with prune belly sequence.
Prenatal Diagnosis.
8:169-174.
1988
|
|
| 1988
|
Regional assignment of six polymorphic DNA sequences on chromosome 21 by in situ hybridization to normal and rearranged chromosomes.
American Journal of Human Genetics.
42:542-549.
1988
|
|
| 1987
|
Preleukemia in Fanconi's anemia: Hematopoietic cell multinuclearity, membrane duplication, and dysgranulogenesis.
Journal of submicroscopic cytology and pathology.
19:355-364.
1987
|
|
| 1987
|
A de novo 3p;8p unbalanced translocation resulting in partial dup(3p) and partial del(8p).
Journal of Medical Genetics.
24:174-177.
1987
|
|
| 1987
|
Lack of association between abnormalities of the chromosome 9 short arm and either 'lymphomatous' features or T cell phenotype in childhood acute lymphocytic leukemia.
Blood.
69:735-738.
1987
|
|
| 1987
|
t(1;19)(q23;p13) in pre-B acute lymphocytic leukemia cell line 697.
Cancer Genetics.
25:379-380.
1987
|
|
| 1987
|
tdic(9;12): A nonrandom chromosome abnormality in childhood B-cell precursor acute lymphoblastic leukemia: A pediatric oncology group study.
Blood.
70:1962-1965.
1987
|
|
| 1986
|
Localization of the LDHA gene to 11p14→11p15 by in situ hybridization of an LDHA cDNA probe to two translocations with breakpoints in 11p13.
Human Genetics.
74:331-334.
1986
|
|
| 1986
|
Establishment of Tac-negative, interleukin-2-dependent cytotoxic cell lines from large granular lymphocytes (LGL) of patients with expanded LGL populations.
Journal of Clinical Immunology.
6:457-466.
1986
|
|
| 1986
|
Granulocytic sarcoma with an indolent course and destructive skeletal disease. Tumor characterization with immunologic markers, electron microscopy, cytochemistry, and cytogenetic studies.
Cancer.
57:1005-1010.
1986
|
|
| 1986
|
Lack of association between glutathione content and development of thermal tolerance in human fibroblasts.
Radiation Research.
106:41-46.
1986
|
|
| 1986
|
Partial trisomy 6p and partial trisomy 22 resulting from 3:1 meiotic disjunction of maternal (6p;22q) translocation.
Journal of Medical Genetics.
23:185-187.
1986
|
|
| 1986
|
Sideroblastic anemia associated with thrombocytosis and a chromosome 3 abnormality.
Cancer Genetics.
22:183-187.
1986
|
|
| 1985
|
Lymphomatous All with Abnormalities of the Short Arm of Chromosome 9.
New England Journal of Medicine.
313:1611-1612.
1985
|
|
| 1985
|
Acute leukemias associated with the 4;11 chromosome translocation have rearranged immunoglobulin heavy chain genes.
Blood.
66:33-38.
1985
|
|
| 1985
|
An acute myeloproliferative disorder characterized by myelofibrosis and blast cells that express phenotypic properties associated with multiple hematopoietic lineages.
American Journal of Clinical Pathology.
83:114-121.
1985
|
|
| 1985
|
The clinical utility of cytogenetic analysis in acute leukemia..
The Alabama journal of medical sciences.
22:90-93.
1985
|
|
| 1985
|
Translocation (6;9)(p23;q34) in acute nonlymphocytic leukemia: Three new cases.
Cancer Genetics.
18:303-306.
1985
|
|
| 1984
|
Clonal Remission in Acute Leukemia.
New England Journal of Medicine.
311:922-923.
1984
|
|
| 1984
|
An unbalanced (6q;13q) translocation in a male with clinical features of Ehlers-Danlos type II syndrome.
Journal of Medical Genetics.
21:226-228.
1984
|
|
| 1984
|
Paternal Robertsonian translocation t(13q;14q) and maternal reciprocal translocation t(7p;13q) in a couple with repeated fetal loss.
Journal of Medical Genetics.
21:463-464.
1984
|
|
| 1984
|
Pre-B cell leukemia associated with chromosome translocation 1;19.
Blood.
63:721-724.
1984
|
|
| 1984
|
Recombination between the fragile X and G6PD..
American Journal of Medical Genetics Part A.
17:275-276.
1984
|
|
| 1984
|
Tetraploidy: A report of three live-born infants.
American Journal of Medical Genetics Part A.
19:29-37.
1984
|
|
| 1984
|
Translocation (9;11)(p21;q23) in a case of acute myeloblastic leukemia (AML-M2).
Cancer Genetics.
12:329-332.
1984
|
|
| 1983
|
Unusual translocations t(2;6) and t(?;22) in a child with acute myelocytic leukemia.
Cancer Genetics.
10:205-208.
1983
|
|
| 1982
|
CYTOGENETICS OF B-CELL LINEAGE ACUTE LYMPHOCYTIC LEUKAEMIAS OF CHILDHOOD
1982
|
|
| 1982
|
Linkage studies in carriers of Lowe oculo-cerebro-renal syndrome.
American Journal of Human Genetics.
34:966-971.
1982
|
|
| 1982
|
Colonic Villous Adenoma: Monoclonal Origin.
Journal of the American Medical Association.
247:829-830.
1982
|
|
| 1981
|
Normal activity and electrophoretic mobility of erythrocyte glucose-6-phosphate dehydrogenase in males with X-linked mental retardation and the fragile Xq..
American Journal of Human Genetics.
33:826-828.
1981
|
|
| 1980
|
CELLULAR EXPRESSION OF WISKOTT-ALDRICH ALLELE
1980
|
|
| 1980
|
A new glucose-6-phosphate dehydrogenase deficient variant in a patient with Chediak-Higashi syndrome.
Blood.
56:476-480.
1980
|
|
| 1980
|
Wiskott-Aldrich syndrome: Cellular impairments and their implication for carrier detection.
Blood.
56:1048-1054.
1980
|
|
| 1979
|
A study of a patient with chronic lymphocytic leukemia (CLL) which demonstrates that proliferation of the lymphocytic clone in CLL does not include T lymphocytes.
Clinical Immunology.
13:231-236.
1979
|
|
| 1978
|
A common progenitor for human myeloid and lymphoid cells [19].
Nature.
274:590-591.
1978
|
|
